§ EQUITY
USD

RNTX

REIN THERAPEUTICS INC
USD
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
39 increased/new, 3 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
Voss Capital, LP4.4M0.3%+3%
BIOS Capital Management, LP2.0M4.9%+17%
VANGUARD CAPITAL MANAGEMENT LLC999Kn/an/a
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO512K0.1%±0%
Cable Car Capital, LP420K0.2%±0%
Prosight Management, LP412K0.1%−7%
◇ AC INTELLIGENCE

Top institutional owners for RNTX as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER90.8% · 34 holders
DEALER / BANK5.3% · 7 holders
PASSIVE / INDEX3.3% · 2 holders
INCOME / DEFENSIVE0.3% · 1 holder
SYSTEMATIC / QUANT0.2% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for RNTX in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention RNTX yet.